Lineage Cell: Q3 Earnings Snapshot

Barchart · 1d ago

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported third-quarter earnings of $4.2 million.

The Carlsbad, California-based company said it had net loss of 3 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.

The biotechnology company posted revenue of $1.4 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $3.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX